Corticotropin
Brand name: Acthar
Rank #145 of 500 drugs by total cost
$111.6M
Total Cost
1,633
Total Claims
$111.6M
Total Cost
94
Prescribers
$68K
Cost per Claim
38
Beneficiaries
1,750
30-Day Fills
$1.2M
Avg Cost/Provider
17
Avg Claims/Provider
About Corticotropin
Corticotropin (sold as Acthar) was prescribed 1,633 times by 94 Medicare Part D providers in 2023, costing the program $111.6M. At $68K per claim, this is a high-cost medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 142 | Vortioxetine Hydrobromide (Trintellix) | $113.9M | 197,873 |
| 143 | Asfotase Alfa (Strensiq) | $113.8M | 1,142 |
| 144 | Erenumab-Aooe (Aimovig Autoinjector) | $111.9M | 118,455 |
| 145 | Corticotropin (Acthar) | $111.6M | 1,633 |
| 146 | Bupropion Hcl (Bupropion Hcl Sr) | $110.0M | 3,323,724 |
| 147 | Dimethyl Fumarate (Dimethyl Fumarate) | $109.8M | 29,208 |
| 148 | Immun Glob G(Igg)/Gly/Iga 0-50 (Gammaplex) | $109.6M | 7,815 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology